X
Search Filters
Format Format
Format Format
X
Sort by Item Count (A-Z)
Filter by Count
Journal Article (7287) 7287
Book Review (1581) 1581
Publication (536) 536
Newsletter (107) 107
Conference Proceeding (35) 35
Magazine Article (32) 32
Book Chapter (30) 30
Newspaper Article (11) 11
Dissertation (3) 3
Trade Publication Article (3) 3
Reference (2) 2
Transcript (2) 2
Web Resource (2) 2
more...
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
index medicus (6439) 6439
humans (5214) 5214
thiazolidinediones - therapeutic use (3701) 3701
hypoglycemic agents - therapeutic use (3425) 3425
male (3065) 3065
thiazolidinediones (2988) 2988
diabetes mellitus, type 2 - drug therapy (2646) 2646
animals (2433) 2433
female (2430) 2430
thiazolidinediones - pharmacology (1806) 1806
middle aged (1678) 1678
rosiglitazone (1625) 1625
pioglitazone (1554) 1554
endocrinology & metabolism (1538) 1538
diabetes (1485) 1485
insulin resistance (1417) 1417
type 2 diabetes (1341) 1341
pharmacology & pharmacy (1290) 1290
aged (1135) 1135
mice (1079) 1079
hypoglycemic agents - pharmacology (1074) 1074
adult (1069) 1069
rats (1058) 1058
hypoglycemic agents - adverse effects (1011) 1011
metformin - therapeutic use (944) 944
ppar-gamma (944) 944
thiazolidinediones - adverse effects (918) 918
ppar gamma - agonists (898) 898
insulin-resistance (868) 868
insulin (860) 860
metformin (860) 860
risk factors (787) 787
abridged index medicus (778) 778
drug therapy, combination (770) 770
troglitazone (759) 759
treatment outcome (746) 746
diabetes mellitus, type 2 - blood (732) 732
glucose (726) 726
thiazoles - therapeutic use (722) 722
thiazolidinediones - administration & dosage (705) 705
blood glucose - metabolism (686) 686
drug therapy (660) 660
hypoglycemic agents - administration & dosage (640) 640
ppar gamma - metabolism (627) 627
diabetes mellitus, type 2 - complications (595) 595
diabetes mellitus (591) 591
hypoglycemic agents (569) 569
research (563) 563
medicine, general & internal (561) 561
care and treatment (547) 547
risk (545) 545
inflammation (517) 517
expression (516) 516
obesity (502) 502
thiazolidinedione (494) 494
mellitus (488) 488
double-blind method (472) 472
sulfonylurea compounds - therapeutic use (470) 470
glycemic control (452) 452
disease models, animal (434) 434
analysis (429) 429
chromans - therapeutic use (427) 427
type-2 diabetes-mellitus (427) 427
activated-receptor-gamma (422) 422
insulin - therapeutic use (402) 402
activated receptor-gamma (399) 399
insulin - blood (397) 397
diabetes mellitus, type 2 - metabolism (393) 393
diabetes mellitus, type 2 - physiopathology (391) 391
diabetes therapy (390) 390
ligands (389) 389
blood glucose - drug effects (388) 388
dose-response relationship, drug (387) 387
metabolism (384) 384
medicine & public health (379) 379
metabolic syndrome (378) 378
therapy (377) 377
internal medicine (372) 372
health aspects (370) 370
gene-expression (364) 364
time factors (355) 355
mice, inbred c57bl (346) 346
glycated hemoglobin a - metabolism (340) 340
physiological aspects (335) 335
dextrose (327) 327
cardiac & cardiovascular systems (321) 321
oxidative stress (321) 321
biochemistry & molecular biology (318) 318
rats, sprague-dawley (318) 318
double-blind (317) 317
rats, wistar (309) 309
diabetes mellitus - drug therapy (308) 308
cancer (303) 303
insulin resistance - physiology (301) 301
myocardial-infarction (301) 301
administration, oral (299) 299
article (299) 299
cells, cultured (298) 298
drugs (298) 298
clinical trials (297) 297
more...
Library Location Library Location
Language Language
Language Language
X
Sort by Item Count (A-Z)
Filter by Count
English (7023) 7023
Japanese (103) 103
German (93) 93
French (74) 74
Chinese (59) 59
Spanish (37) 37
Russian (16) 16
Dutch (9) 9
Danish (7) 7
Hungarian (7) 7
Swedish (6) 6
Norwegian (5) 5
Czech (4) 4
Italian (4) 4
Polish (4) 4
Portuguese (3) 3
Bulgarian (2) 2
Finnish (2) 2
Korean (2) 2
Ukrainian (2) 2
Lithuanian (1) 1
Romanian (1) 1
more...
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


ANNALS OF INTERNAL MEDICINE, ISSN 0003-4819, 01/2011, Volume 154, Issue 2, pp. 103 - 103
Background: Insulin replacement in diabetes often requires prandial intervention to reach hemoglobin A(1c) (HbA(1c)) targets. Objective: To test whether... 
NPH INSULIN | MEDICINE, GENERAL & INTERNAL | GLYCEMIC CONTROL | ORAL-THERAPY | ADD-ON | GLUCOSE-LOWERING DRUGS | COMBINATION THERAPY | PARALLEL-GROUP | NAIVE PEOPLE | OPEN-LABEL | TO-TARGET TRIAL | Metformin - therapeutic use | Glycated Hemoglobin A - metabolism | Humans | Middle Aged | Body Weight - drug effects | Male | Thiazolidinediones - administration & dosage | Peptides - administration & dosage | Thiazolidinediones - therapeutic use | Hypoglycemic Agents - administration & dosage | Injections, Subcutaneous | Sensitivity and Specificity | Venoms - administration & dosage | Female | Insulin - analogs & derivatives | Metformin - administration & dosage | Drug Therapy, Combination | Hypoglycemic Agents - therapeutic use | Insulin, Long-Acting | Double-Blind Method | Drug Administration Schedule | Venoms - adverse effects | Insulin - administration & dosage | Diabetes Mellitus, Type 2 - blood | Insulin Glargine | Venoms - therapeutic use | Aged | Diabetes Mellitus, Type 2 - drug therapy | Hypoglycemic Agents - adverse effects | Insulin - therapeutic use | Peptides - adverse effects | Peptides - therapeutic use | Type 2 diabetes | Glycosylated hemoglobin | Physiological aspects | Research | Diagnosis | Drug therapy | Injections | Side effects | Clinical trials | Diabetes | Hypoglycemia | Insulin | Weight | Index Medicus | Abridged Index Medicus
Journal Article
Diabetes Care, ISSN 0149-5992, 02/2012, Volume 35, Issue 2, pp. 252 - 258
Journal Article
Lancet, The, ISSN 0140-6736, 2009, Volume 373, Issue 9681, pp. 2125 - 2135
Summary Background Rosiglitazone is an insulin sensitiser used in combination with metformin, a sulfonylurea, or both, for lowering blood glucose in people... 
Internal Medicine | CARDIAC OUTCOMES | METFORMIN | MEDICINE, GENERAL & INTERNAL | MONOTHERAPY | MYOCARDIAL-INFARCTION | SULFONYLUREAS | HEART-ASSOCIATION | RISK | COMPLICATIONS | BLOOD-GLUCOSE CONTROL | FAILURE | Glycated Hemoglobin A - analysis | Myocardial Infarction - mortality | Body Weight | Metformin - therapeutic use | Prospective Studies | Humans | Middle Aged | Fractures, Bone - epidemiology | Hospitalization - statistics & numerical data | Male | Drug Utilization | Thiazolidinediones - therapeutic use | Cholesterol, LDL - blood | Female | Stroke - mortality | Drug Therapy, Combination | Heart Failure - epidemiology | Hypoglycemic Agents - therapeutic use | Administration, Oral | Sulfonylurea Compounds - therapeutic use | Angina, Unstable - epidemiology | Hydroxymethylglutaryl-CoA Reductase Inhibitors - therapeutic use | Sex Factors | Cholesterol, HDL - blood | Diuretics - therapeutic use | Diabetes Mellitus, Type 2 - drug therapy | Neoplasms - epidemiology | Type 2 diabetes | Patient outcomes | Dosage and administration | Drug therapy, Combination | Research | Metformin | Rosiglitazone maleate | Drug therapy | Health aspects | Heart failure | Studies | Clinical trials | Data collection | Blood pressure | Diabetes | Marketing | Index Medicus | Abridged Index Medicus | Medical and Health Sciences | MEDICINE | Medicin och hälsovetenskap | MEDICIN
Journal Article
Journal Article
Diabetes, Obesity and Metabolism, ISSN 1462-8902, 02/2014, Volume 16, Issue 2, pp. 147 - 158
Journal Article